Massachusetts General Hospital/Dana Farber — Boston, Massachusetts

Massachusetts General Hospital/Dana Farber is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital/Dana Farber has participated in 1 clinical trials.

Therapeutic areas: Ependymoma, Anaplastic Ependymoma.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital/Dana Farber?

Massachusetts General Hospital/Dana Farber has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital/Dana Farber conducted?

Massachusetts General Hospital/Dana Farber has 1 clinical trials on record. Their work covers Ependymoma, Anaplastic Ependymoma.

Is Massachusetts General Hospital/Dana Farber accredited by Crixeo Health?

Massachusetts General Hospital/Dana Farber has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital/Dana Farber?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.